- $169.43bn
- $173.90bn
- $14.37bn
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,784 | 7,679 | 9,633 | 12,726 | 14,368 |
Cost of Revenue | |||||
Gross Profit | 5,617 | 6,301 | 7,950 | 10,320 | 11,225 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 4,930 | 5,503 | 7,133 | 10,155 | 11,227 |
Operating Profit | 1,854 | 2,176 | 2,500 | 2,571 | 3,141 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,881 | 2,198 | 2,556 | 2,542 | 2,989 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,557 | 1,826 | 2,062 | 2,066 | 2,384 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,557 | 1,826 | 2,062 | 2,066 | 2,384 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,557 | 1,826 | 2,062 | 2,066 | 2,384 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.9 | 6.92 | 7.55 | 7.27 | 8.42 |
Dividends per Share |